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Objective: This retrospective nonrandomized study investigated the outcomes of endovascular therapy for long-segment
atherosclerotic aortoiliac occlusion.
Methods: From May 2008 to January 2013, 20 patients (one woman and 19 men; mean age, 66.1 years; range, 43-
89 years) underwent stent implantation, with or without catheter-directed thrombolysis (CDT), for long-segment aor-
toiliac occlusion (>10 mm).
Results: The technical success rate was 95% (19 of 20). No in-hospital mortality was recorded. Aortic thrombus was
successfully eliminated with CDT in four patients before percutaneous transluminal angioplasty (PTA) and stenting.
Retroperitoneal hemorrhage occurred in one patient, who refused further endovascular surgery. Another 15 patients
were treated with PTA and stenting. Postoperative ankle-brachial indexes increased signiﬁcantly from preoperative values
(P < .05). Seventeen patients showed clinical improvement from baseline by an average of 2.5 Rutherford categories. The
mean follow-up interval was 17.6 months (range, 4-39 months). The primary patency rates were 93.3% 6 6.4% at
6 months, 83% 6 11.3% at 18 months, and 66.4% 6 17.4% at 24 months.
Conclusions: Through brachial and femoral artery puncture, PTA, stenting, and CDT, endovascular therapy is feasible for
complete long-segment infrarenal aortic occlusion, with lower complication rates and favorable midterm patency. (J Vasc
Surg 2014;59:663-8.)Complete aortoiliac occlusion, deﬁned as a TransAt-
lantic Inter-Society Consensus (TASC) type D lesion, is
classically associated with claudication, rest pain, toe
gangrene, and absent or diminished peripheral pulses.
Short focal lesions (<10 cm) of the aorta and iliac
arteries are best treated by endovascular approaches,
whereas complete long-segment aortoiliac occlusion
lesions (>10 cm) have been principally treated with
surgical bypass.1,2 Aortobifemoral bypass has good
long-term patency rates but with signiﬁcant major
morbidity and mortality, especially for elderly patients
with comorbidities.3-5
The equipment and technology for endovascular
surgery has rapidly advanced in recent years, providing
a variety of tools for the treatment of complex peripheral
lesions. However, the technical success in crossing these
TASC type D lesions remains lower than that for TASC
type A to C lesions, largely owing to the difﬁculty of re-
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://dx.doi.org/10.1016/j.jvs.2013.09.005Long-segment aortoiliac occlusion usually begins with
atherosclerotic disease at and around the aortic bifurcation,
with the lesion encroaching on the vessel lumen, resulting
in aortic stenosis, slow blood ﬂow, turbulence, and
thrombus formation that completes the occlusion proxi-
mally as far as a signiﬁcant outﬂow branch, often the infe-
rior mesenteric or renal arteries.7
This study retrospectively investigated the outcomes
of endovascular therapy for long-segment TASC type D
aortoiliac occlusion by stenting, with or without catheter-
directed thrombolysis (CDT), and assessed its feasibility
and safety.
METHODS
From May 2008 to January 2013, 20 consecutive
symptomatic patients (1 woman and 19 men; mean age,
66.1 years; range, 43-89 years) with long-segment
(>10 cm) TASC type D aortoiliac occlusion extending
to the common or external iliac arteries were treated
with endovascular techniques in our hospital (Table I).
The study excluded patients with inﬂammatory occlusive
vascular diseases, such as Takayasu disease involving aor-
toiliac arteries, and aortoiliac occlusion caused by
thromboembolism.
Patient comorbidities included hypertension, coronary
artery disease, diabetes mellitus, atrial ﬁbrillation, chronic
renal insufﬁciency, hyperlipidemia, cerebral infarction,
and smoking (Table I). Our clinical indication for endovas-
cular therapy was moderate to severe claudication or critical
limb ischemia.
Preprocedural assessment was performed by means
of computed tomography angiography or magnetic reso-
nance angiography, and reconstructions were obtained to663
Table I. Patient characteristics
Characteristics
No. (%) or mean (range)
(n ¼ 20)
Male 19 (95)
Age, years 66.1 (43-89)
Comorbidities
Hypertension 17 (85)
Coronary artery disease 11 (55)
Diabetes mellitus 6 (30)
Atrial ﬁbrillation 4 (20)
Chronic renal insufﬁciency 4 (20)
Hyperlipidemia 8 (40)
Cerebral infarction 5 (25)
Smoking 15 (75)
Fig 1. Computed tomography angiography demonstrates that the
occlusion starts proximally at the level of the infrarenal aorta and
extends distally to the common superﬁcial femoral artery.
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occlusion level, and distal runoff vessels of the lesion
(Fig 1).
Procedural angiograms with bilateral lower extremity
runoff demonstrated proximal occlusion at the level of
the renal artery in 5 patients, between the renal artery
and the inferior mesenteric artery (IMA) in 4 patients, at
the IMA in 6 patients, and between the IMA and the aortic
bifurcation in 5 patients. Distal occlusion at the level of the
common iliac artery was observed in six patients and at the
level of the external iliac artery in 14. Among all of them,
15 patients had tandem outﬂow arterial lesions. None of
the patients had a history of surgical or endovascular inter-
vention in the aortic or iliac vessels (Table II).
Symptoms were classiﬁed according to the Rutherford
category8: class II, moderate claudication, in 2 patients;
class III, severe claudication, in 8; class IV, ischemic rest
pain, in 8; and class V, minor tissue loss, in 2.
Written informed consent was obtained from each
patient after a detailed explanation of the risks and beneﬁts
of the procedure. All procedures were performed in the
angiography unit under local anesthesia. Heparin (125
IU/kg) was administered intra-arterially after placement
of a 6F vascular sheath.
Access to the artery in ﬁve patients was obtained
directly with bilateral common femoral artery puncture.
After the occlusion was crossed, the pigtail catheter was
advanced into the aorta at the level of the renal arteries
for the initial arteriogram. Antegrade access from the left
brachial artery was required in 15 patients, and a pigtail
catheter was advanced for the initial arteriogram. Then,
the complete long-segment occlusion was crossed to the
femoral artery. The iliac and aortic occlusions were success-
fully crossed with two 0.035-inch hydrophilic guidewires in
all patients.
According to the position, type, and length of lesions,
15 patients were treated solely with percutaneous translu-
minal angioplasty (PTA) and stenting, and ﬁve were treated
with CDT, followed by PTA and stenting. Proximal aortic
occlusion at the renal artery level was the most common
indication for thrombolysis, which involved continuous
and pulse-spray infusion of urokinase (30,000 IU/h)
through the UniFuse Infusion catheter (AngioDynamics,Queensbury, NY) placed in the recanalized aorta and
iliac artery. In 18 patients, the entire occluded segment
was predilated with Admiral Xtreme balloons (6-8 mm in
diameter  80-120 mm in length; Invatec, Roncadelle,
Italy), and the aorta and the common iliac arteries were
stented with self-expandable S.M.A.R.T. stents (8-10 mm
in diameter  60-120 mm in length; Cordis, Miami Lakes,
Fla) through the “kissing” technique (ie, two self-
expandable stents). Direct stenting was performed in the
other two patients. The self-expandable stents were dilated
with Admiral Xtreme balloons of the same size (6-8 mm in
diameter  80-120 mm in length) after the deployment.
The ﬁnal result was documented with an angiogram.
Technical success was deﬁned as restored vessel patency
with a residual diameter stenosis of <30% and a transle-
sional pressure gradient of <5 mm Hg.9 Clinical success
was deﬁned as a subjective perception of improved walking
distance that resulted in an improved classiﬁcation accord-
ing to the Rutherford category.8
Patients were discharged on an oral regimen of
aspirin (100 mg/d), clopidogrel (75 mg/d), and statins
(20 mg/d). Clinical examination and duplex ultrasound
imaging were performed before discharge, at 1, 3, and
6 months after discharge, and every 6 months thereafter.
Restenosis was deﬁned as >2.4 of peak systolic velocity
Table II. Clinical symptoms and lesion characteristics
Characteristics
No. (%) or mean 6 SD
(n ¼ 20)
Level of proximal aortic occlusion
At the renal artery level 5 (25)
Between renal and IMA 4 (20)
At the IMA level 6 (30)
Between IMA and aortic bifurcation 5 (25)
Level of distal aortic occlusion
Common iliac artery 6 (30)
External iliac artery 14 (70)
Rutherford category
Preoperative
II, moderate claudication 2 (10)
III, severe claudication 8 (40)
IV, ischemic rest pain 8 (40)
V, minor tissue loss 2 (10)
Postoperative
No symptom 4 (20)
I, mild claudication 11 (55)
II, moderate claudication 4 (20)
ABI
Preoperative
Right 0.36 6 0.11
Left 0.33 6 0.12
Postoperative
Right 0.87 6 0.18
Left 0.84 6 0.13
Tibial pressures, mm Hg
Preoperative
Right 56 6 19
Left 51 6 17
Postoperative
Right 129 6 26
Left 125 6 21
ABI, Ankle-brachial index; IMA, inferior mesenteric artery; SD, standard
deviation.
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done by measuring the baseline ankle-brachial index
(ABI), which was calculated as the highest brachial artery
pressure divided by the highest tibial pressure. Radiologic
evaluation was performed using color Doppler ultrasound
imaging in all patients and contrast-enhanced computed
tomography, if necessary.
The cumulative patency rates were assessed with
Kaplan-Meier curve by Graphpad Prism 5.0 software
(GraphPad Software Inc, San Diego, Calif). The statistical
differences in ABI values and Rutherford classiﬁcation
before and after intervention were analyzed with the paired
nonparametric test. P < .05 was considered statistically
signiﬁcant.
RESULTS
Complete reconstruction of long-segment occluded
aortoiliac arteries, with re-establishment of unimpeded
blood ﬂow to both legs, was successfully achieved in 19
of 20 patients (95%). Multiple access sites were needed
for all patients, and the brachial artery was the most
common access site initially in 15 patients.
Aortic thrombus was successfully eliminated with CDT
in four of ﬁve patients (80%) patients before PTA andstenting. Intra-arterial urokinase was administered after
the wire and UniFuse Infusion catheter crossed the
occluded lesions in these four patients. The mean duration
of the urokinase infusion was 27 hours (range, 20-38 hours;
Fig 2).
No distal embolization was found during intraoperative
angiography. Retroperitoneal hemorrhage occurred in one
of the ﬁve CDT patients at 3 hours postoperatively, with
a decline in blood pressure and lower hemoglobin. After
stopping CDT and rehydration, this patient recovered
gradually but refused further endovascular surgery.
Other complications in the access site occurred in one
patient (5%), who developed an expanding groin hema-
toma after manual compression. No patients experienced
distal embolization or impaired renal function during the
procedure, and there were no periprocedural deaths or
other complications.
After a mean follow-up of 17.6 months (range, 4-
39 months), 10 patients with ischemic pain or tissue loss
showed signiﬁcant improvements in symptoms, and nine
patients with intermittent claudication had gained unre-
stricted walking distance. Four patients improved
completely, 11 improved to Rutherford category 1
(mild claudication), and 4 were in Rutherford category
2 (moderate claudication), which corresponded to an
improvement by 3 categories in 12 patients, by 2 cate-
gories in 5 patients, and by 1 category in 2 patients.
The difference in the distributions of Rutherford category
between baseline and follow-up was statistically signiﬁcant
(P < .001).
The ABI was calculated on the basis of Doppler pres-
sure measurements. As expected, the mean ABI had risen
from 0.36 6 0.11 on the right and 0.33 6 0.12 on the
left preoperatively to 0.87 6 0.18 on the right and
0.84 6 0.13 on the left postoperatively, both of which
were statistically signiﬁcant (P < .01, Table II). Mean-
while, mean tibial pressures improved from 56 6 19 on
the right and 56 6 17 on the left preoperatively to
129 6 26 on the right and 125 6 21 on the left post-
operatively, both of which were statistically signiﬁcant
(P < .01, Table II).
All 19 patients were implanted with self-expandable
stents (mean, 2.3; range, two-four) in the aortoiliac arteries
through the kissing stent method. The superﬁcial femoral
artery was recanalized simultaneously in three patients.
In-stent restenosis (deﬁned as >70% recurrent
luminal narrowing) of the common iliac artery was diag-
nosed in three patients on the basis of duplex ultrasound
results at 6, 18, and 24 months, respectively. All three
patients with poor distal runoff refused interventional
treatment because they experienced only little physical
compromise. One patient died of pulmonary infection
at 13 months postoperatively, and one died of myocardial
infarction at 14 months (Table III). The patency rates
were obtained according to the Kaplan-Meier method,
and the primary patency rates were 93.3% 6 6.4% at
6 months, 83% 6 11.3% at 18 months, and 66.4% 6
17.4% at 24 months (Fig 3).
Fig 2. Digital subtraction angiography: A, The infrarenal abdominal aorta was completely occluded. B, The aortic and
left iliac arteries were unobstructed, and their walls were smooth 24 hours after catheter-directed thrombolysis (CDT).
C, At 24 hours after repeated CDT of the right iliac artery, its opening is narrow and the distal iliac artery is patent.
D, Bare metal stents (8  80 mm) were placed into the right iliac artery, and both iliac arteries were patent.
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The common treatment of long-segment atheroscle-
rotic aortoiliac occlusion has been surgical bypass graft
placement (eg, aortobifemoral bypass grafting), which
has a 5-year patency rate of w80% to 85%.5 However,
surgical treatment is associated with signiﬁcant periopera-
tive morbidity and mortality in high-risk patients4-6 and is
also generally associated with delayed recovery and pro-
longed hospitalization.
Endovascular therapy has proven to be an excellent
alternative to open surgery, especially for short stenoses
of the aorta and the iliac arteries.10-14 Various authors
have described the deployment of stents for short-
segment aortoiliac occlusion. However, only few studies
have reported the outcomes of endovascular therapy forlong-segment atherosclerotic aortoiliac occlusion.15,16 In
this report, we describe our successful experience with an
exclusively endovascular approach for reconstructing
long-segment aortoiliac occlusions in a consecutive series
of 20 patients (despitew500 patients with peripheral arte-
rial disease being admitted to our hospital annually). In-
hospital mortality (0%) and postoperative complications
(10.5%) after endovascular therapy were signiﬁcantly lower
than that of aortobifemoral bypass reported by previous
studies.17
Long-segment complete aortoiliac occlusion usually
results from stasis of blood secondary to narrowing or
occlusion of the aortoiliac bifurcation and of both iliac
arteries. The atherosclerotic plaque alone does not neces-
sarily occlude the aorta; thrombus frequently accumulates
Table III. Follow-up results
Patient Follow-up time, months Restenosis, month
1 13
2 16 6
3 Died of pulmonary infection
13 months post-op
4 17
5 18
6 22
7 20
8 21 18
9 Died of myocardial infarction
14 months post-op
10 25
11 5
12 39
13 13
14 28 24
15 28
16 24
17 15
18 12
19 Hemorrhage during CDT, failed
surgery, no follow-up
20 4
CDT, Catheter-directed thrombolysis.
Fig 3. Kaplan-Meier estimates of primary patency.
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 3 Yuan et al 667in the narrowed aorta as a result of turbulence and slowing
of blood ﬂow.18 Although the aortoiliac occlusion is long,
it may include atherosclerotic plaque and thrombus and the
narrow point is relatively short. We thus believe that endo-
vascular treatment and CDT can potentially be effective for
these lesions.
Although previous studies consider that thrombolysis is
only for acute arterial thrombosis, intra-arterial CDT may
be also suitable for some nonacute patients by a continuous
infusion of urokinase. CDT therapy has been used for
treating thromboembolism in patients with aortic bifurca-
tion occlusion.19,20 In addition, Schmalstieg et al21 showed
that thrombotic occlusion proximal to the aortic stent after
direct stenting resulted in inﬂow obstruction in one
patient. Moise et al16 suggest the presence of thrombus
close to the renal arteries is the most common indication
for thrombolysis. In this study, we also thought that direct
PTA and stent deployment for those ﬁve patients with anoccluded lesion at the renal artery level might cause
embolus formation in the renal artery owing to the
compression by the balloon and stent. Furthermore, it
was relatively easy to get through the proximal occlusion
in those ﬁve patients, so CDT was initially used to eliminate
intra-aortic thrombus before PTA and stent deployment,
which was only performed based on surgeon preference,
as described by Moise et al.16
Embolic complications caused by CDT have been re-
ported. In the Kim et al19 study, thrombolytic agents
were administered in 21 patients, and four (19.0%) devel-
oped acute distal embolization. Diethrich et al20 reported
two patients (28.6%) with embolic complications related
to thrombolytic infusion with urokinase before stent place-
ment for treating complete abdominal aortic occlusion.
However, no distal embolization was observed in our
study. We therefore think that CDT is suitable for some
patients with acute aggravating thrombus on a chronic
basis according to the history and the long lesions being
crossed easily, especially the aortoiliac lesions near the renal
arteries.
Retroperitoneal bleeding occurred in one patient
(5.0%), which may have been caused by branch artery
injury during the subintimal angioplasty. Thus, subintimal
angioplasty should be carefully avoided to prevent aortoil-
iac perforation and rupture, and a low-dose continuous and
pulse-spray infusion of urokinase thrombolysis may be safe
and effective to decrease the risk of hemorrhage.
The other 15 patients were treated directly with PTA
and stent deployment, without preliminary thrombolysis.
Stenting with predilation was used in most of our patients
without thrombotic debris embolization, and direct stent-
ing, followed by postdilation, was performed in two
patients. In several other studies, however, the stent was
directly deployed without predilation to reduce the risk
of distal embolism.16,19,22-24 We prefer to perform predila-
tion for chronic patients because the middle and distal
arteries do not need stenting after dilation, which could
reduce the length of the stents. We also chose the most
suitable stents for occluded arteries, and as expected,
thrombotic debris embolization to more distal blood
vessels was seldom observed in chronic lesions.
Self-expandable stents were used for long-segment
occluded arteries in our study for their excellent ﬂexibility
and capability to adapt to the vessel’s tortuosity compared
with balloon-expandable stents. Bare-metal stents, instead
of covered stents, were implanted to preserve the aortic
and iliac side branches. However, covered stents may be
used for severely calciﬁed iliac vessels to avoid arterial
rupture from balloon inﬂation.22
Brachial artery access, which was used in 15 patients in
our study, is a critical component of endovascular proce-
dures for long-segment complete aortoiliac occlusion.
Nyman et al3 report that the low success rate in the recon-
struction of aortobiiliac occlusions is because of the lack of
attempts to use a brachial access site. Brachial artery access
may be chosen in the absence of palpable femoral pulses
and because more complex techniques require multiple
JOURNAL OF VASCULAR SURGERY
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recanalization rate from the brachial artery is higher than
the retrograde rate from the femoral artery because the
initial lesion is nearly at the aortic bifurcation and it is easier
for a retrograde guidewire to enter the subintimal space
and harder to return into the true lumen in serious
lesions.24 When an occlusion was crossed, we were able
to remove the wire from the femoral artery by using the
“crossing sheath technique.” With the same methods, we
could remove the wire from another femoral artery, form-
ing a kiss guidewire. Another advantage of antegrade access
through the brachial artery is that it presents little risk of
aortic dissection secondary to subintimal wire passage.
Owing to the above advantages, primary patency rates
were 93.3% 6 6.4%, 83% 6 11.3%, and 66.4% 6 17.4% at
6, 18, and 24 months, respectively, which are comparable
to those after bypass surgery.5 Similar with other series,
poor arterial runoff may be associated with a higher risk
of in-stent restenosis.25,26 None of the three patients
underwent further endovascular treatment because they
experienced only a little physical compromise, and all had
survived at the last follow-up.
CONCLUSIONS
Through brachial and femoral artery puncture, PTA,
stenting, and CDT, endovascular therapy is feasible for
most patients with complete long-segment infrarenal aortic
occlusion, with very low complication rates. The midterm
patency of endovascular treatment for long-segment total
occluded aortoiliac lesions is also favorable. However,
a multicenter study with a large sample size is still needed
to conﬁrm our conclusion.
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